Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$651M |
| 2 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$622M |
| 3 |
Merck
MRK
|
+$496M |
| 4 |
Adobe
ADBE
|
+$446M |
| 5 |
CRH
CRH
|
+$410M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.33B |
| 2 |
Microsoft
MSFT
|
+$965M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$542M |
| 4 |
NVIDIA
NVDA
|
+$522M |
| 5 |
Linde
LIN
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.03% |
| 2 | Technology | 8.55% |
| 3 | Healthcare | 6.96% |
| 4 | Financials | 6.02% |
| 5 | Industrials | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Werner Enterprises
WERN
$2.3B
| $2.8M | ﹤0.01% |
71,545
-239,772
| -77% | -$9.56M |
|
3327
PUT
Lantheus
LNTH
$6.58B
| $2.79M | ﹤0.01% |
44,900
+24,700
| +122% | +$1.45M |
|
3328
Nektar Therapeutics
NKTR
$2.48B
| $2.79M | ﹤0.01% |
198,970
+92,560
| +87% | +$969K |
|
3329
Astronics
ATRO
$3.26B
| $2.79M | ﹤0.01% |
175,668
-242,790
| -58% | -$3.61M |
|
3330
Ardmore Shipping
ASC
$709M
| $2.79M | ﹤0.01% |
169,710
+154,805
| +1,039% | +$2.46M |
|
3331
Telefônica Brasil
VIV
$18.2B
| $2.78M | ﹤0.01% |
276,367
+44,290
| +19% | +$466K |
|
3332
Smith-Midland
SMID
$133M
| $2.78M | ﹤0.01% |
59,233
+43,610
| +279% | +$1.78M |
|
|
MRSH
3333
PUT
Marsh
MRSH
$91.9B
| $2.78M | ﹤0.01% |
13,500
-7,100
| -34% | -$1.42M |
|
3334
Invesco S&P 500 Low Volatility ETF
SPLV
$7.03B
| $2.78M | ﹤0.01% |
42,205
+34,919
| +479% | +$2.23M |
|
3335
Criteo S.A.
CRTO
$855M
| $2.78M | ﹤0.01% |
79,128
-450,992
| -85% | -$13.5M |
|
3336
PUT
Northern Trust
NTRS
$34.2B
| $2.77M | ﹤0.01% |
+31,200
| New | +$2.56M |
|
3337
Rigel Pharmaceuticals
RIGL
$868M
| $2.77M | ﹤0.01% |
187,299
+109,715
| +141% | +$1.48M |
|
3338
Deutsche Bank
DB
$75.8B
| $2.77M | ﹤0.01% |
175,730
+113,302
| +181% | +$1.55M |
|
3339
Black Diamond Therapeutics
BDTX
$128M
| $2.77M | ﹤0.01% |
546,237
+424,428
| +348% | +$1.71M |
|
3340
Twin Disc
TWIN
$333M
| $2.76M | ﹤0.01% |
166,957
+106,434
| +176% | +$1.67M |
|
3341
PUT
BioMarin Pharmaceuticals
BMRN
$12.5B
| $2.75M | ﹤0.01% |
31,500
-31,500
| -50% | -$2.82M |
|
3342
Sensient Technologies
SXT
$5.75B
| $2.75M | ﹤0.01% |
39,719
-14,214
| -26% | -$922K |
|
3343
Vanguard FTSE Emerging Markets ETF
VWO
$127B
| $2.75M | ﹤0.01% |
65,734
-46,589
| -41% | -$1.9M |
|
|
GAP
3344
PUT
The Gap Inc
GAP
$8.45B
| $2.74M | ﹤0.01% |
99,600
-435,000
| -81% | -$9.17M |
|
3345
PagerDuty
PD
$1.09B
| $2.74M | ﹤0.01% |
120,790
-288,996
| -71% | -$6.86M |
|
|
3346
CALL
Northern Trust
NTRS
$34.2B
| $2.74M | ﹤0.01% |
+30,800
| New | +$2.53M |
|
|
SBXC.U
3347
DELISTED
SilverBox Corp III Units, each consisting of one Class A Common Stock and one-third of one redeemable warrant
SBXC.U
| $2.74M | ﹤0.01% |
250,000
| – | – |
|
|
CGC
3348
Canopy Growth
CGC
$449M
| $2.74M | ﹤0.01% |
317,373
+228,110
| +256% | +$984K |
|
3349
CALL
Antero Resources
AR
$11.8B
| $2.73M | ﹤0.01% |
94,200
-1,226,500
| -93% | -$29.6M |
|
3350
CALL
Okta
OKTA
$29.1B
| $2.73M | ﹤0.01% |
26,100
+18,900
| +263% | +$1.74M |
|
Similar funds
Israel Englander's Q1 2024 Portfolio in Review
As of Q1 2024, Israel Englander held 6,887 positions worth $234B, up 1.3% from $231B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Israel Englander's Q1 2024 filing shows 858 new, 2,292 increased, 2,484 reduced and 745 closed positions. Its largest new stake was iShares Bitcoin Trust: 20,859,447 shares worth $844M. The largest sale was iShares Core S&P 500 ETF, an estimated $4.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q1 2024 buy was iShares Bitcoin Trust: 20,859,447 shares worth $844M.
- Israel Englander added most to Merck in Q1 2024, an estimated $496M increase.
- Israel Englander's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.33B.
- Israel Englander fully exited Splunk Inc in Q1 2024, selling an estimated $319M.
- Israel Englander's ten largest holdings make up 17% of its $234B portfolio in Q1 2024.
- Israel Englander opened 858 new positions and closed 745 in Q1 2024.
- Israel Englander's portfolio value rose 1.3% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.